US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by PROCEPT BioRobotics
< Previous
1
2
Next >
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
August 17, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
August 04, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
July 14, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
May 28, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
May 14, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
April 30, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
April 29, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
April 09, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
March 23, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
March 12, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth
February 26, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
February 25, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
February 23, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
February 04, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
January 26, 2026
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
November 20, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
November 04, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
October 15, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
August 06, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
July 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
July 23, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
July 21, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
July 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
April 29, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
April 10, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
March 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
March 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
February 25, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
< Previous
1
2
Next >
